Gain of 12p material is invariably associated with testicular germ cell tumors (TGCTs) of adolescents and adults, most usually as an isochromosome 12p. We analyzed TGCTs with i(12p) using a global approach to expression profiling targeting chromosomes (comparative expressed sequence hybridization, CESH). This indicated overexpression of genes from 12p11.2-p12.1 relative to testis tissue and fibroblasts. The nonseminoma subtype showed higher levels of expression than seminomas. Notably, 12p11.2-p12.1 is amplified in about 10% of TGCTs and CESH analysis of such amplicon cases showed high levels of overexpression from this region. Microarray analysis, including cDNA clones representing most UniGene clusters from 12p11.2-p12.1, was applied to DNA and RNA from 5 TGCTs with amplification of 12p11.2-p12.1 and seven TGCTs with gain of the entire short arm of chromosome 12. Expression profiles were consistent with the CESH data and overexpression of EST595078, MRPS35 and LDHB at 12p11.2-p12.1 was detected in most TGCTs. High-level overexpression of BCAT1 was specific to nonseminomas and overexpression of genes such as CMAS, EKI1, KRAS2, SURB7 and various ESTs correlated with their amplification. Genes such as CCND2, GLU3, LRP6 and HPH1 at 12p13 were also overexpressed. The overexpressed sequences identified, particularly those in the region amplified, represent candidate genes for involvement in TGCT development.
Gain of 12p material is invariably associated with testicular germ cell tumors (TGCTs) of adolescents and adults, most usually as an isochromosome 12p. We analyzed TGCTs with i(12p) using a global approach to expression profiling targeting chromosomes (comparative expressed sequence hybridization, CESH). This indicated overexpression of genes from 12p11.2-p12.1 relative to testis tissue and fibroblasts. The nonseminoma subtype showed higher levels of expression than seminomas. Notably, 12p11.2-p12.1 is amplified in about 10% of TGCTs and CESH analysis of such amplicon cases showed high levels of overexpression from this region. Microarray analysis, including cDNA clones representing most UniGene clusters from 12p11.2-p12.1, was applied to DNA and RNA from 5 TGCTs with amplification of 12p11.2-p12.1 and seven TGCTs with gain of the entire short arm of chromosome 12. Expression profiles were consistent with the CESH data and overexpression of EST595078, MRPS35 and LDHB at 12p11.2-p12.1 was detected in most TGCTs. High-level overexpression of BCAT1 was specific to nonseminomas and overexpression of genes such as CMAS, EKI1, KRAS2, SURB7 and various ESTs correlated with their amplification. Genes such as CCND2, GLU3, LRP6 and HPH1 at 12p13 were also overexpressed. The overexpressed sequences identified, particularly those in the region amplified, represent candidate genes for involvement in TGCT development.
Introduction
Testicular germ cell tumors (TCGTs) of adolescents and adults comprise 1% of all malignancies in men and have been reported as increasing in incidence over the last several decades in Caucasian populations (Bosl and Motzer, 1997) . Although the majority of TGCTs are curable, these tumors are the leading cause of cancer death in young men (Bosl and Motzer, 1997) . The tumors are classified into two main subtypes; the seminomas and the nonseminomas. Various characteristics including their sensitivity to cis-platinum-based treatment and genetic changes suggest a common etiology for these subtypes. Seminomas frequently present clinically at a more advanced age than nonseminomas, suggesting a slower rate of progression (Oosterhuis et al., 1989) . TGCTs are generally considered to be derived from carcinoma in situ (CIS), which develop in utero and do not progress until after puberty (reviewed by Rorth et al., 2000) .
A striking feature of all invasive TGCTs is gain of material from the short arm of chromosome 12. This is because of an isochromosome 12p in 80% of cases (reviewed by Sandberg et al., 1996) . In approximately 10% of primary TGCTs, amplification in the 12p11.2-p12.1 region has been reported (Suijkerbuijk et al., 1993; Mostert et al., 1996; Korn et al., 1996; Rao et al., 1998; Summersgill et al., 1998a; Roelofs et al., 2000) . This has been predominantly found in seminomas although it has been seen in nonseminomas but in a more heterogeneous cellular pattern. The amplification is present mainly in seminomas without an i(12p) although gain of the entire short arm of 12p has been characterized in addition to the amplification (Roelofs et al., 2000) . Seminomas with amplification at 12p11.2-p12.1 have been associated with an earlier age of clinical presentation than seminomas with gain of the entire 12p, and have been related to reduced sensitivity of the tumor cells to undergo apoptosis (Roelofs et al., 2000) . Neither gain nor amplification of 12p material has been detected in CIS, although many of the other chromosome imbalances associated with TGCTs were already present in CIS adjacent to invasive tumor (Rosenberg et al., 2000; Summersgill et al., 2001a) . This indicates that 12p gain is associated with the progression of CIS to invasive disease.
It is likely that the amplification leads to overexpression of genes that are involved in TGCT progression, as has been found in other tumor types (Hayes and Thor, 2002) . However, as the gain of the entire short arm of chromosome 12 is such a consistent feature and is found in addition to amplification of the 12p11.2-p12.1 region, it is likely that genes outside the amplified region on 12p may also be involved.
To further understand the role of 12p in the development of TGCTs, we investigated the overall expression patterns along chromosome 12 in TGCTs with and without amplification at 12p11.2-p12.1. We have profiled the expression patterns along this chromosome using two approaches: (i) using a novel approach, we developed, which targets chromosome preparations and indicates chromosome regions containing genes that are relatively under-and overexpressed (Lu et al., 2001) ; and (ii) using microarray analysis to identify overrepresented and overexpressed genes and expressed sequences in TGCTs with gain of the entire short arm of chromosome 12 and TGCTs that also have amplification at 12p11.2-p12.1 (Figure 1 ).
Results

Comparative expressed sequence hybridization (CESH) analysis
CESH analysis was carried out to profile the expression changes along the length of chromosome 12 in various TGCTs with gain of the entire 12p region and also amplification at 12p11.2-p12.1 (Table 1) . Direct comparison of the human foreskin fibroblast cultures and/or normal testicular parenchyma used as controls showed little difference along the length of 12p, except for a small dip in the very telomeric region suggesting relative underexpression from genes in this region in normal testicular tissue (Figure 2a ). CESH analysis of the cell lines in Table 1 , which are all of nonseminomatous origin, showed relative overexpression from the 12p11.2-p12.1 region, which exceeded that from other regions on 12p. The CESH analysis of the primary seminoma (SE7) and nonseminoma (NS9), known to have uniform gain of the entire 12p region also indicated relative overexpression of genes from the 12p11.2-p12.1 region (Figure 2b, c) . The level of overexpression was less in the seminoma compared to the nonseminoma.
The CESH profiles of cases with amplicons (aSE1, aSE2) showed a similar pattern although the maximum ratios of fluorescence intensity were higher than the nonamplicon cases. Direct comparison of seminomas with and without 12p11.2-p12.1 amplification (aSE4 vs SE6 and aSE4 vs SE7) showed relative overexpression from 12p peaking at the region of amplification ( Figure  2d , e). Comparing two nonseminoma without evidence for amplification of the 12p11.2-p12.1 region (NS9 vs NS10) showed no differential expression on 12p (data not shown). These data show that relative overexpression of genes from 12p11.2 to 12p12.1 is likely to be important in all TGCT, irrespective of amplification.
Identification of amplified clones by CGH microarray analysis
To define the region of amplification at the level of cDNA clones, we applied microarray CGH analysis to cDNA clones for chromosome 12 (www.icr.ac.uk/ rodriguez/). The microarray data for the cell line GCT27 and cases known to have uniform gain of 12p material were analyzed, and examples of the profiles obtained are shown in Figure 3a -d.
The log 2 ratio of fluorescence intensities for amplified clones was generally in excess of 1.5, whereas 1.5-0.3 was considered as gain and 070.3 as normal. The 1og 2 ratio of fluorescent intensities for the clones on 12p outside the region amplified in the amplicon cases was generally greater than 0.3 and greater than those for clones on 12q (070.3). This suggests gain of 12p material in addition to the amplification and is consistent with the copy number of YAC markers determined by interphase FISH analysis in this study and previously (Zafarana et al., 2002) . The results of the CGH microarray analysis of the five TGCTs with 12p11.2-p12.1 amplicons are presented in Figure 3e -h, and the clones amplified in each case are indicated in Tables 2 and 3 . The profiles for aSE2 and aSE4 suggest two maximum peaks of amplification interspersed with a lower level of gain at around 24MB (Figure 3h, j) . This is consistent with the pattern of amplification determined by microarray data with BAC clones for the same cases (Zafarana, unpublished data) .
A few clones were identified as amplified although according to the databases mapped outside the 12p amplicon region on 12p or on other chromosomes. These clones correspond to two ESTs (ID number 230420, 122163) and to a gene from our geneset named glycogen synthase (245920). We confirmed that these clones are likely to map to 12p and within the amplified region through hybridization to DNA from GCT27 and the YACs 845d11 and/or 922d2, which were shown to be amplified in some cases (Figure 1 ). These YACs were positioned against the cDNA clones as indicated in Figure 3b through their hybridization to the microarray. 
Microarray expression profiling of genes and ESTs
Examples of expression profiling by microarray analysis of the TGCTs with and without 12p amplification are shown in Figure 4a -d. The highest relative levels of expression corresponded to the region amplified at 12p11.2-p12.1 with the highest ratios seen in the seminomas with amplicons, followed by the nonseminomas and finally the seminomas without amplification. This pattern is consistent with the CESH pattern. The microarray expression data are presented in Tables 2  and 3 . Overexpression of EST595078, MRPS35 and LDHB at 12p11.2-p12.1 was detected in most TGCTs. High-level overexpression of BCAT1 was specific to nonseminomas and overexpression of the genes CMAS, EKI1, LRMP, KRAS2, C12orf2, ITPR2, FLJ10637, TM7SF3, SURB7 and various ESTs (AJ511866, 242113, 428900, 1501595, 587245) correlated with their amplification. Genes such as CCND2, MLF2, PTMS, GLU3, HPH1 and LRP6 at 12p13 were also overexpressed. The ESTs 230420, 122163 and glycogen synthase that were mapped here to the region which is amplified (see above) were not overexpressed in seminomas with amplification relative to either testicular parenchyma or seminomas without amplification.
Confirmation of relative overexpression by quantitative RT-PCR
To confirm the overexpression of some of the genes detected by microarray analysis, quantitative RT-PCR has been used to measure the levels of expression of KRAS2, BCAT1 and PEPP2 ( Figure 5 ). The expression level of these genes quantified by real-time RT-PCR is consistent with the data obtained by the microarray profiling in all but two data points for each gene, which appear to represent minor discrepancies on the limit of detection by microarray analysis. Relative overexpression of KRAS2 was seen in the amplicon vs nonamplicon cases. High-level overexpression of BCAT1 was specific to nonseminomas and derived cell lines. Normal lymphocytes were shown not to express these genes to 12p Expression profiling in testicular germ cell tumors S Rodriguez et al any significant level although their contamination in most primary samples could dilute the expression levels measured ( Figure 5 ). However, KRAS2 has been reported to be expressed in lymphocytes infiltrating TGCTs (Zafarana et al., 2002) .
Discussion
As gain of 12p material is found in all invasive TGCTs, it is an important research goal to identify candidate genes from this chromosome arm that are likely to be involved in the pathogenesis of these tumors. Despite the fact that the characteristic i(12p) was described 20 years ago (Atkin and Baker, 1982) few 12p genes have been implicated. We report here on the overall expression patterns of genes along the length of chromosome 12 in nonseminomas and seminomas. We have included TGCTs with and without amplification at 12p11.2-12.1 and highlight the importance of genes from the 12p11.2 to 12p12.1 region in the development of TGCTs. Here, we have identified a number of new candidate genes for involvement in TGCTs development. The expression analysis of chromosome 12 using the global approach of CESH that targets chromosomes, revealed overexpression relative to controls of genes from 12p11.2 to 12p12.1 in all TGCTs. The level of overexpression from this region was higher in nonseminomas than in seminomas. In seminomas, amplification increased the relative level of expression. Differential expression from this chromosomal region has not been found in a range of normal tissues nor in excess of 100 tumors including various sarcomas and prostate carcinomas that have been analysed by CESH (Lu et al., 2001 and unpublished data) . This suggests that overexpression of genes from 12p11.2 to 12p12.1 is a feature of all TGCTs and overexpression of genes from this region, particularly in nonseminomas and seminomas with amplification, may play a key role in driving TGCT progression.
In order to identify genes responsible for this general pattern of expression and candidate genes for involvement in TGCTs, microarray expression profiling was undertaken. The expression profiles of chromosome 12 ( Figure 4) were consistent with the CESH pattern and involved overexpression of various genes and expressed sequences at 12p11.2-p12.1 (Tables 2 and 3) . Quantitative RT-PCR for BCAT1, KRAS2 and PEPP2 was consistent at most data points with the microarray expression analysis of these genes ( Figure 5) , and highlighted the approximate limits of detection of our microarray analysis. Approximately 10-fold or greater overexpression, measured by quantitative RT-PCR, was detected by microarray as a two to fivefold fluorescence ratio. In excess of 50-fold increase in expression measured by real-time RT-PCR corresponded to a microarray ratio greater than 5. Therefore, the sensitivity of microarray expression analysis is limited and may miss subtle changes in gene expression that could be critically important.
In order to identify candidate genes from 12p for involvement in TGCT development, it is possible to use the minimum overlapping region of amplification to indicate the region containing key genes. The cDNA microarray analysis of TGCT DNA was consistent with Summersgill et al. (1998a, b) 12p Expression profiling in testicular germ cell tumors S Rodriguez et al FISH analysis using region-specific probes and defined the minimum overlapping region of amplification in the cases studied here as between the CMAS gene at 22.57Mb and EST 595078 at 27.54Mb ( Figure 3 , Table 2 ). The smallest overlapping region of amplification previously reported is smaller than this one extending from EKI1 at 23.16Mb to the DAD-R gene, which is adjacent to BCAT1 at 25.4Mb (Zafarana et al., 2002) . Unfortunately, no material suitable for microarray analysis was available from this case. In addition to the region amplified, gain of 12p material was indicated in most cases by the elevated fluorescence ratios on 12p compared to 12q. This was supported by our interphase FISH analysis ( Figure 1 ) and is consistent with previous interphase FISH studies (Roelofs et al., 2000) . A small increase in copy number of markers from the amplified region has also been noted in a cell line (Summersgill et al., 2001b) . Subtle differences in the copy number of markers can make it difficult to delineate the extent of amplification by these methods. An alternative approach using microarrays of BAC clones has been applied to investigate the structure of 12p11.2-p12.1 amplification. Preliminary data indicate the presence of two peaks of amplification within the region (Zafarana, unpublished observation) , which is consistent with the pattern observed here by micro- Based on their copy number increase, a number of genes from 12p have been previously suggested as candidates for involvement including SOX5, LRMP, KRAS2, LDHB, SSPN (KRAG) and ITPR2. In addition, in regions of amplification studied in other tumors, the level of overexpression of particular genes may be excessive and exceed that expected from the level of amplification, for example, the GLI1 gene in glioma (Kinzler et al., 1987) . Thus, amplification and high-level overexpression may indicate good candidate genes. Expression analysis of some amplified genes in TGCTs has supported a potential role for DADR and recently LOC51026 and FLJ10637 (Bourdon et al., 2002; Zafarana et al., 2002) . In the present study a number of genes identified as amplified were shown to be overexpressed and could potentially play a role in the progression of TGCTs. Overexpression of genes in the minimal region of amplification in this study included CMAS, EKI1, LRMP (JAW1), KRAS2, C12orf, ITPR2, TM7SF3 and SURB7 (Table 2) . CMAS is involved in ganglioside synthesis, EKI1 plays a role in phosphatidylethanolamine biosynthesis and binding of IP3 to ITPR2 is associated with calcium release from intracellular stores and signal transduction. KRAS2, TM7SF3 and SURB7 encode a member of the small GTPase superfamily, a seven-transmembrane protein and a component of the RNA polymerase II holoenzyme, respectively. These genes are therefore associated with proliferation and/or cell survival and their deregulation could be involved in the proposed role of 12p amplification enhancing cell survival outside the microenvironment of the tubules (Roelofs et al., 2000) . In addition, we have confirmed FLJ10637 as amplified and frequently overexpressed (Bourdon et al., 2002) and identified a number of new candidate ESTs -AJ511866, 242113 428900, 1501595 and 587245 for which there is no known function. EKI1 and the ESTs 242113 and AJ511866 that are localized in the amplified region in this study are also within the smaller minimum region previously reported (Zafarana et al., 2002) . The BCAT1 gene (branched chain aminotransferase 1) lies within the minimum region of amplification, but was found to be highly overexpressed in the nonseminomas studied compared to all seminomas, irrespective of amplification. The level of BCAT1 expression as measured by quantitative RT-PCR was slightly higher in seminomas with amplification than in other seminomas, and overall this suggests its role in nonseminoma development ( Figure 5 ). BCAT1 is a target gene for CMYC (Benvenisty et al., 1992) , which is involved in cell proliferation, differentiation and apoptosis, and plays an important role in many tumors. It has been suggested that CMYC target genes may also be regulated by NMYC (Ben-Yosef et al., 1998) and in line with this and previous findings we have found upregulation of NMYC in many of the samples studied here (Skotheim et al., 2002 ; data not shown).
A number of genes and expressed sequences outside the minimum region of amplification were amplified and overexpressed in some cases. These include LOC51026, which is consistent with a recent report (Bourdon et al., 2002) , and ABCC9 and SLC21A3. In addition, LDHB, MRSP35, PEPP2, EST 595078, CCND2, PTMS, HPH1, LRP6 and GLU3 were overexpressed in most cases irrespective of amplification. LDHB and CCND2 overexpression has been previously described in TGCT and confirms the performance of our system (Houldsworth et al., 1997; von Eyben et al., 2000) . LDHB encodes lactate dehydrogenase and has been suggested as an essential factor for cell growth and survival during proliferation (Hinoi et al., 2002) . GLU3 (a glucose transporter type 3) that is overexpressed in most TGCTs is thought to enhance expression of LDHB. These overexpressed 12p genes that were not amplified could also play a role in TGCT development and may reflect the consistent gain of all 12p that is associated with invasive TGCTs.
The data presented here demonstrate the ability to identify systematically amplified and overexpressed genes as candidates for involvement in a particular tumor type. The work emphasizes the potential key role of genes on 12p, and 12p11.2-p12.1 in particular, that are likely to play a role in the development of TGCTs. Having profiled changes in gene expression, The black boxes indicate genes or ESTs with relatively high overexpression (ratio>5). Gray boxes indicate overexpression at a lower level (ratio 2-5). White indicates no detectable expression difference between TGCTS and control. X was where particular clones were not available in a particular experiment. The thick lines with unenclosed boxes indicate the clones that were determined as amplified in the individual cases The black boxes indicate genes or ESTs with relatively high overexpression (ratio>5). Gray boxes indicate overexpression at a lower level (ratio 2-5). White indicates no detectable expression difference between TGCTS and control. X was where particular clones were not available in a particular experiment. The thick lines with unenclosed boxes indicate the clones that were determined as amplified in the individual cases 12p Expression profiling in testicular germ cell tumors S Rodriguez et al further studies are now required to investigate the role that proteins encoded by the ESTs and candidate genes highlighted here play in the development of TGCTs.
Materials and methods
Sample selection and preparation
In all, 20 snap-frozen primary TGCTs samples (seven seminomas, eight nonseminomas and five combined tumors) were screened by comparative genomic hybridization (CGH) analysis in order to identify cases with amplicons at 12p11.2-p12.1. This was carried out as previously described using the QUIPS CGH analysis software (Vysis, Chicago, IL, USA) (Summersgill et al., 1998b) . A further four cases with previously published amplicons at 12p11.2-p12.1 were available (Summersgill et al., 2001b; Zafarana et al., 2002) . The primary samples and cell lines indicated in Table 1 were used for the CESH and microarray analyses. The extent of the amplicons in aSE3, aSE4 and aSE5 have been previously reported (Zafarana et al., 2002) . Cases aSE1 and aSE2 were characterized here by interphase FISH. YACs from the 12p11.2-p12.1 region Figure 1 and YACs mapping just above the centromere (770a11) and near the telomere (812c9 and 814e6) (www.genome.wi.mit.edu) were used in combination with a differentially labeled chromosome 12-centromere probe (pBr12) as previously described (Baldini et al., 1990; Windstetter et al., 1997) . The data from this analysis and the positions of the YACs are summarized in Figure 1 . Samples were assessed for the proportion of tumor cells vs infiltrating lymphocytes on the basis of morphology following standard hematoxylin and eosin staining (Table 1) . Cultured human foreskin fibroblasts and snap-frozen normal testicular tissue were used as controls for the expression profiling. Genomic DNA was prepared using established methods (Sambrook and Russell, 2001) . RNA was extracted using Trizol (Life Technologies, Grand Island, NY, USA) according to the manufacturer's instructions.
CESH analysis
CESH analyses were performed as previously described (Lu et al., 2001 ). Self-to-self hybridizations were carried out and ratios in excess of 0.8-1.2 were determined as cutoffs in defining regions corresponding to differential expression. Five good-quality metaphases were karyotyped and the chromosome 12 s analysed. Particular attention was paid to individual profiles rather than averaged profiles as CESH ratio changes may involve small regions that are reduced because of misalignment (Lu et al., 2001) .
Microarray preparation and analysis
A chromosome 12 specific array was prepared and tested (see below 12p Expression profiling in testicular germ cell tumors S Rodriguez et al identified by screening a GCT27 cDNA library with YACs ( Figure 1 ) and 4454 clones from the Institute of Cancer Research and Cancer Research UK Geneset were also included. DNA was gridded onto poly-l-lysine-coated glass slides and hybridized with fluorescently labeled samples derived from either 2 mg DNA or RNA as previously described (Lu et al., 2001) . Scanning and data analysis were basically carried out as previously described (Lu et al., 2001) . The scatter plot was straightened based on the median Cy5 and Cy3 foreground intensity, using statistical locally weighted regression and smoothing of the scatter plots (Cleveland, 1979) . A statistical identification of outliers was performed by the method described previously (Clark et al., 2002) to detect amplification events. The ratio of fluorescence intensities was calculated with the straightened data to assess the fold increase associated with each spot. To identify false-positive clones, normal-to-normal hybridizations were performed. Clones with a log 2 ratio in excess of 0.3 were considered as outliers with a P-value of 0.005 and only two such clones were identified. Assuming that the gain of 12p in the cell line GCT27 (nine copies of 12p compared to three copies of 12q) included all genes on this chromosome arm, the microarray data were used to identify 12p clones that were not responding (Pollack et al., 1999) . Such false-positive and -negative clones, respectively, were excluded from the analysis, however, as clones were gridded in triplicate and multiple clones from the same gene were included, information on only a few genes was lost. A total of 314 unique sequences on chromosome 12 were represented, of which 151 were from 12p with most UniGene clusters represented from 12p11.2 to 12p12.1 (informative clones listed at www.icr.ac.uk/rodriguez/). In addition, clones in each experiment were excluded if there were gridding errors.
Quantitative RT-PCR analysis
Quantitative RT-PCR was performed using the ABI PRISM 7700 Sequence Detection System according to the manufacturer's instructions (www.appliedbiosystems.com: Applied Biosystems, Foster City, CA, USA). B-2-microglobulin was used as the endogenous control.
